43742-0776 NDC - LYME PLUS (ARNICA MONTANA, CALENDULA OFFICINALIS, ECHINACEA (ANGUSTIFOLIA), MYRRHA, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, TRIGONELLA FOENUM-GRAECUM, URTICA DIOICA, HYDRASTIS CANADENSIS, PROPOLIS, ADRENALINUM, GUNPOWDER, THYMUS (SUIS), THYROIDINUM (SUIS), ARSENICUM ALBUM, COCCULUS INDICUS, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RHUS TOX, BABESIA MICROTI, BORRELIA BURGDORFERI NOSODE, EHRLICHIA NOSODE (CANINE), ENCEPHALITIS NOSODE, LEDUM PALUSTRE, MENINGOCOCCUS NOSODE)

Drug Information

Product NDC: 43742-0776

Proprietary Name: Lyme Plus

Non Proprietary Name: Arnica Montana, Calendula Officinalis, Echinacea (Angustifolia), Myrrha, Phytolacca Decandra, Taraxacum Officinale, Trifolium Pratense, Trigonella Foenum-Graecum, Urtica Dioica, Hydrastis Canadensis, Propolis, Adrenalinum, Gunpowder, Thymus (Suis), Thyroidinum (Suis), Arsenicum Album, Cocculus Indicus, Iridium Metallicum, Lycopodium Clavatum, Phosphorus, Rhus Tox, Babesia Microti, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (Canine), Encephalitis Nosode, Ledum Palustre, Meningococcus Nosode

Active Ingredient(s):
  • 3 [hp_X]/mL ARNICA MONTANA;
  • 3 [hp_X]/mL CALENDULA OFFICINALIS FLOWERING TOP;
  • 3 [hp_X]/mL ECHINACEA ANGUSTIFOLIA;
  • 3 [hp_X]/mL MYRRH;
  • 3 [hp_X]/mL PHYTOLACCA AMERICANA ROOT;
  • 3 [hp_X]/mL TARAXACUM OFFICINALE;
  • 3 [hp_X]/mL TRIFOLIUM PRATENSE FLOWER;
  • 3 [hp_X]/mL FENUGREEK SEED;
  • 3 [hp_X]/mL URTICA DIOICA;
  • 6 [hp_X]/mL GOLDENSEAL;
  • 6 [hp_X]/mL PROPOLIS WAX;
  • 8 [hp_X]/mL EPINEPHRINE;
  • 8 [hp_X]/mL ACTIVATED CHARCOAL;
  • 8 [hp_X]/mL SULFUR;
  • 8 [hp_X]/mL POTASSIUM NITRATE;
  • 8 [hp_X]/mL SUS SCROFA THYMUS;
  • 8 [hp_X]/mL SUS SCROFA THYROID;
  • 12 [hp_Q]/mL ARSENIC TRIOXIDE;
  • 12 [hp_X]/mL ANAMIRTA COCCULUS SEED;
  • 12 [hp_X]/mL IRIDIUM;
  • 12 [hp_X]/mL LYCOPODIUM CLAVATUM SPORE;
  • 12 [hp_X]/mL PHOSPHORUS;
  • 12 [hp_X]/mL TOXICODENDRON PUBESCENS LEAF;
  • 15 [hp_X]/mL BABESIA MICROTI;
  • 15 [hp_X]/mL BORRELIA BURGDORFERI;
  • 15 [hp_X]/mL EHRLICHIA CANIS;
  • 15 [hp_X]/mL JAPANESE ENCEPHALITIS VIRUS;
  • 30 [hp_X]/mL LEDUM PALUSTRE TWIG;
  • 30 [hp_X]/mL NEISSERIA MENINGITIDIS;
  • 33 [hp_X]/mL HEPATITIS B VIRUS


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Labeler Information

Labeler Name: Deseret Biologicals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:6/14/2016
End Marketing Date:7/9/2021

Package Information

No. Package Code Package Description Billing Unit
143742-0776-130 mL in 1 BOTTLE, DROPPER (43742-0776-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43742-0776The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELyme PlusThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEArnica Montana, Calendula Officinalis, Echinacea (Angustifolia), Myrrha, Phytolacca Decandra, Taraxacum Officinale, Trifolium Pratense, Trigonella Foenum-Graecum, Urtica Dioica, Hydrastis Canadensis, Propolis, Adrenalinum, Gunpowder, Thymus (Suis), Thyroidinum (Suis), Arsenicum Album, Cocculus Indicus, Iridium Metallicum, Lycopodium Clavatum, Phosphorus, Rhus Tox, Babesia Microti, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (Canine), Encephalitis Nosode, Ledum Palustre, Meningococcus NosodeThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/14/2016This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE7/9/2021This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDeseret Biologicals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEARNICA MONTANA; CALENDULA OFFICINALIS FLOWERING TOP; ECHINACEA ANGUSTIFOLIA; MYRRH; PHYTOLACCA AMERICANA ROOT; TARAXACUM OFFICINALE; TRIFOLIUM PRATENSE FLOWER; FENUGREEK SEED; URTICA DIOICA; GOLDENSEAL; PROPOLIS WAX; EPINEPHRINE; ACTIVATED CHARCOAL; SULFUR; POTASSIUM NITRATE; SUS SCROFA THYMUS; SUS SCROFA THYROID; ARSENIC TRIOXIDE; ANAMIRTA COCCULUS SEED; IRIDIUM; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF; BABESIA MICROTI; BORRELIA BURGDORFERI; EHRLICHIA CANIS; JAPANESE ENCEPHALITIS VIRUS; LEDUM PALUSTRE TWIG; NEISSERIA MENINGITIDIS; HEPATITIS B VIRUSThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH3; 3; 3; 3; 3; 3; 3; 3; 3; 6; 6; 8; 8; 8; 8; 8; 8; 12; 12; 12; 12; 12; 12; 15; 15; 15; 15; 30; 30; 33 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 9/13/2019